Trump family-linked investment group American Ventures has acquired $31.3mn in convertible shares of XWell, a wellness company developing AI-powered infectious disease screening for airports. The deal, managed by Dominari Securities' Trump Tower-based subsidiary, aims to deploy the technology during the World Cup in June. XWell, valued at under $3mn during the transaction, combines medical diagnostics with airport spas and waxing salons across Florida and internationally.

The investment vehicle, structured through Dominari's American Ventures SPV, holds 31,333 preferred shares convertible into 66.6mn common shares at $0.47. This follows XWell's partnership with AI startup PieQ to create a "next generation intelligence layer" for handling travel surges during events like the 2026 World Cup. XWell reported a $17mn net loss in 2025, with 60% revenue from its 25 XpresSpa locations offering manicures, massages, and LED treatments in airports worldwide.

Dominari Securities, parent company to American Ventures, saw 2025 revenue surge 500% to $123mn despite a widened $55.7mn net loss. The firm has shifted focus from Chinese IPOs to US tech and defense investments after regulatory scrutiny. Its Trump-connected advisory board includes Eric and Donald Trump Jr, who previously backed a Pentagon-contract drone firm through another American Ventures entity.

The transaction highlights growing interest in biosecurity solutions for public health infrastructure. XWell's dual business model of medical services and wellness tourism reflects post-pandemic market trends. Regulatory challenges loom as US-China investment scrutiny intensifies, with Dominari previously investigated for pump-and-dump schemes involving Chinese stocks.